17-alpha Hydroxyprogesterone Caproate: Clinical Trials

2 trials of 17-alpha Hydroxyprogesterone Caproate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow 17-alpha Hydroxyprogesterone Caproate: new trials by email Literature Review of 17-alpha Hydroxyprogesterone Caproate trials Research Report on 17-alpha Hydroxyprogesterone Caproate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Improving Pregnancy Outcomes With Progesterone
17P, Placebo - Pre-term Birth, HIV-1-infection
Phase 3CompletedUniversity of North Carolina, Chapel Hill8002018-02-072021-07-22
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
17-alpha Hydroxyprogesterone Caproate, Castor oil - Preterm Delivery
Phase 2CompletedAmerican University of Beirut Medical Center2902006-10-012013-07-19

Conditions studied

Premature Birth (2)

Sponsors

American University of Beirut Medical Center (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

Lebanon (1)  ·  Zambia (1)

Top investigators

Anwar H Nassar, MD (1)  ·  Jeff Stringer, MD, FACOG (1)

Results publications

PMID 30813934, PMID 34509197

NIH funding

R01HD087119 (1)